G1 Therapeutics Inc
Biotechnology
Healthcare
GTHX
61.04 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
3.13
52 week high
8.93
high
3.42
52 week low
1.34
low
3.04
growth
-50.79 %
previous Close
3.05
P/E ratio
market cap
96.86 M
div yield
0
usd
Jun 2023
qoq
revenue
42.39 M
227.45 %
net incoming
8.71 M
126.77 %
eps
0.00 %
126.42 %
eps surprise
163.64 %
net profit margin
20.55 %
271.00 %
operating incoming
11.52 M
144.73 %
net change in cash
-12.32 M
53.25 %
cash on hand
55.91 M
-51.93 %
cost of revenue
1.40 M
-3.77 %
top top